In this study, we not only confirmed that serum EV concentrations were higher in patients with T2DM, but also accurately measured and highlighted the higher levels of GDF15 in serum EV in T2DM patients compared to non-T2DM patients. This evidence concerns the gene GDF15 and type 2 diabetes mellitus.